Related Experiment Video
Updated: May 3, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.4K
Erectile dysfunction in the cardiology practice-a patients' perspective.
Melianthe P J Nicolai1, Joyce van Bavel1, G Aernout Somsen2
1Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
American Heart Journal
|January 21, 2014
Summary
Erectile dysfunction (ED) is common in cardiovascular patients. Men with ED desire improved sexual health care, including discussions with cardiologists, specialized nurses, and written information for better sexual function.
Area of Science:
- Cardiology
- Sexual Medicine
- Public Health
Background:
- Erectile dysfunction (ED) is a significant risk factor for cardiovascular events, sharing common risk factors with coronary artery disease.
- Current guidelines recommend cardiologists inquire about erectile function, but male patients' specific needs for sexual healthcare in cardiology remain unclear.
Purpose of the Study:
- To identify male patients' perspectives on improving sexual health care within cardiology practices.
- To determine preferred methods of sexual counseling for men with cardiovascular conditions.
Main Methods:
- A cross-sectional, multicentered survey study was conducted.
- Randomly selected males visiting a cardiologist were included as respondents.
Main Results:
- Of 296 eligible respondents (mean age 62.9 years), 56% had ED, with prevalence reaching 86% in heart failure patients.
- Most patients (88%) felt comfortable discussing sexual health with cardiologists. 46% of men with ED desired conversations about improving sexual function, 55% favored consultations with a specialized nurse, and 58% preferred written information.
Conclusions:
- Erectile dysfunction is highly prevalent across various cardiovascular diagnoses, necessitating dedicated sexual function care.
- Patients indicated that consultations with specialized nurses and access to written information are valuable adjuncts to cardiologist consultations for managing sexual health.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
01:23Assessment of the Cardiovascular System I: Subjective Data
1.0K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:20Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
823
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
823